The Latest in IT Security

Another personal genetics firm, GeneLink Biosciences, has been charged with false advertising by the Federal Trade Commission (FTC), on the grounds that the company didnt have the requisite scientific grounds to market its services to consumers. According to FTC officials speaking to Scientific American, GeneLinks claims got ahead of the science, and the company was thereby making unsubstantiated health claims that could put consumers at risk. By taking action against GeneLink […] we were trying to indicate to this industry we were aware of the claims being made, said Carolynn Hann, lead attorney on the case, and we wanted the industry to understand where we stand on these issues. Officials with the FTC wouldnt disclose whether theyre pursuing similar actions against other personal genetics firms, but it is clear that the claims being made by GeneLink were markedly different than those that got 23andMe into hot water with the FDA last year.